William Blair & Company
Tracked across 30 events · 489 articles · First seen Nov 19, 2025 · Last active Aug 24, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: William Blair & Company is hosting the Growth Stock Conference where Allot will meet with investors, facilitating the interaction between the company and potential investors.
May 27, 2026 · 6 articles
Regulatory
LegalZoom.com, Inc. (LegalZoom) reduced its full-year 2026 revenue guidance to approximately $795-$805 million from $810-$830 million and guided third-quarter revenue to approximately $194 million, below analyst estimates, in its August 5, 2026 second-quarter release. The…
Impact: William Blair also downgraded LegalZoom, citing search-channel uncertainty. This added to the negative analyst sentiment and downward pressure on the stock.
Aug 10, 2026 · 7 articles
Business
Impact: William Blair & Company acted as the lead manager for Kailera Therapeutics's IPO, facilitating the offering and earning underwriting fees.
Apr 16, 2026 · 8 articles
Business
Impact: William Blair is a joint book-running manager, participating in the offering and earning fees.
Aug 04, 2026 · 6 articles
Business
Impact: William Blair & Company is one of the 16 banks participating in smaller roles for the SpaceX IPO.
Mar 27, 2026 · 61 articles
Business
Impact: William Blair & Company is hosting one of the investor conferences where OptimizeRx will participate, providing a platform for corporate presentations and meetings.
Jun 01, 2026 · 6 articles
Business
Impact: William Blair & Company is acting as a joint bookrunning manager for Neurogene's public offering.
Jun 30, 2026 · 6 articles
Business
Impact: William Blair analysts encouraged buying Coinbase shares, citing diversification and derivatives-driven share gains, which may support investor confidence.
Jul 31, 2026 · 6 articles
Business
BridgeBio Pharma Pharma, Inc. announced the launch and subsequent pricing of a secondary public offering of 5,000,000 shares of its common stock by the selling stockholder KKR & Co. Genetic Disorder L.P. The company is…
Impact: William Blair is acting as a joint book-running manager for the offering, earning fees for its role in facilitating the transaction.
Aug 13, 2026 · 8 articles
Business
Andersen Group Inc. announced the pricing of an underwritten public offering of 4,284,457 shares of its Class A common stock by certain selling stockholders at $44.00 per share, with gross proceeds of approximately $188.5 million.…
Impact: William Blair is an additional book-running manager, participating in the offering and earning associated fees.
Aug 17, 2026 · 6 articles
Business
Impact: William Blair & Company is hosting the 46th Annual Growth Stock Conference where USA Rare Earth will present.
Jun 01, 2026 · 7 articles
Business
Impact: William Blair & Company is acting as a bookrunner for the offering, participating in the distribution of shares.
Jun 01, 2026 · 8 articles
Business
Impact: William Blair is hosting the 46th Annual Growth Stock Conference where United States — MedlinePlus will present.
May 27, 2026 · 6 articles
Business
Impact: William Blair initiated coverage on AMD with a bullish outlook, calling it a major beneficiary of the AI infrastructure boom.
Jul 06, 2026 · 6 articles
Business
Impact: William Blair & Company served as a financial advisor to FDH Aero and Audax Private Equity in connection with the transaction.
Jun 08, 2026 · 6 articles
Business
Impact: William Blair is acting as an additional book-running manager for the proposed secondary offering of Pattern Group Inc. shares.
Jun 15, 2026 · 6 articles
Tech
Moderna and Merck announced on August 19, 2026, that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy drug Pembrolizumab, met its primary and key secondary endpoints in a Phase 3 trial for…
Impact: William Blair analyst Myles Minter said the results position both companies well for regulatory approval.
Aug 19, 2026 · 108 articles
Business
Impact: Investment bank; provided analyst commentary on the deal.
Jul 06, 2026 · 34 articles
Business
Impact: William Blair is an additional bookrunning manager for the IPO, participating in the underwriting syndicate.
Jul 07, 2026 · 8 articles
Business
Impact: William Blair acted as additional bookrunning manager, earning underwriting fees.
Jul 20, 2026 · 19 articles
Business
Impact: William Blair acted as a placement agent in connection with the concurrent private placement financing.
Apr 14, 2026 · 7 articles
Business
Impact: Analyst firm; Andrew Jeffrey provided commentary on bid price.
Jul 15, 2026 · 96 articles
Business
Impact: Analyst firm that commented on regulatory approval likelihood.
Jul 29, 2026 · 10 articles
Business
Impact: William Blair & Company analysts provided commentary on the Adobe Inc.-Semrush deal, expressing positivity about Adobe restarting its M&A engine but noting the deal's limited impact on creative cloud business questions.
Nov 19, 2025 · 6 articles
70
William Blair & Company downgraded LegalZoomLegalZoom cuts guidance,...
70
William Blair & Company lowered estimates ARS PharmaceuticalsARS Pharmaceuticals...
50
William Blair & Company said results position for approvalModerna Merck mRNA...
40
William Blair & Company underwrote IPO Black Rock Coffee BarBlack Rock Coffee...
ERGEN INTELLIGENCE
Track William Blair & Company live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard